Mp33-12 Industry Payments to Urologists in 2022: Descriptive Analysis of the Open Payments Program Database

You have accessJournal of UrologyHealth Services Research: Quality Improvement & Patient Safety II (MP33)1 May 2024MP33-12 INDUSTRY PAYMENTS TO UROLOGISTS IN 2022: DESCRIPTIVE ANALYSIS OF THE OPEN PAYMENTS PROGRAM DATABASE Joseph Cheaib, Zhuo Su, Zeyad Hammadeh, Bruce J. Trock, and Misop Han Joseph CheaibJoseph Cheaib , Zhuo SuZhuo Su , Zeyad HammadehZeyad Hammadeh , Bruce J. TrockBruce J. Trock , and Misop HanMisop Han View All Author Informationhttps://doi.org/10.1097/01.JU.0001009520.30626.80.12AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Financial incentives may influence physician decision-making. The Open Payments Program (OPP) from the Centers for Medicare and Medicaid Services (CMS) now mandates medical device and pharmaceutical manufacturers to publicly report such incentives given to physicians. The OPP Payments fall under 3 main categories: general payments, research payments, and physician ownership/investment interest. This study aims to describe all open payments made to urologists in 2022. METHODS: All urologists in the US who received at least one payment in the OPP database in 2022 were included. Urologists were identified when the principal investigator reported their practicing specialty as urology. Descriptive analyses of payments by type, sex, and industry payer were performed. RESULTS: Open payments totaling $149,287,170 were made to 8,063 (62.2%) urologists in 2022. Research payments ($96,270,845) were the largest category, followed by general payments ($30,853,188) and then ownership ($22,163,137) (Table 1). The median payment to urologists in 2022 was $524, and the highest-paid urologist received a total of $8,354,885 (6% of all payments). Notably, top 10 urologists received 26% of all payments. Almost all urologists in this cohort (99%) received general payments; over 50% of these general payments were non-continuing medical education-related compensations. 38 urologists (0.47% of all urologists receiving payments) accepted payments of all 3 categories, receiving a total of $29 million (20% of all payments made to urologists). Boston Scientific and Urovant Sciences contributed the biggest number of individual payments, while Merck contributed the largest total amount ($32.6M) (Table 2). CONCLUSIONS: Disproportionate amount of industry payments were made with 0.1% of urologists receiving 26% of the total payments in 2022. Research payments are the largest industry payment category to urologists. Further studies are warranted to better understand the nature of this industry-urologist relationship and its impact on physician decision making. Source of Funding: None © 2024 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 211Issue 5SMay 2024Page: e564 Advertisement Copyright & Permissions© 2024 by American Urological Association Education and Research, Inc.Metrics Author Information Joseph Cheaib More articles by this author Zhuo Su More articles by this author Zeyad Hammadeh More articles by this author Bruce J. Trock More articles by this author Misop Han More articles by this author Expand All Advertisement PDF downloadLoading ...